By
David W. Dowdy, MD PhD and Richard E. Chaisson, MD
Published: Jan. 11, 2013, 8:27 p.m.·
Tags:
None
We should not debate post-2015 targets without first shaping pre-2015 goals to better reflect today’s TB pandemic and the tools - new drugs, integrated HIV-TB services, and molecular diagnostics - that we now have to fight it.
Read More →